Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Selection Based on Therapeutic Targets in Advanced Pancreatic Cancer
NCT01394120Phase 2Unknown
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, irinotecan, oxaliplatin, gemcitabine, capecitabine in pancreatic ductal adenocarcinoma (PDAC). Status: unknown.
02
Drugs
fluorouracilirinotecanoxaliplatingemcitabinecapecitabine
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01394120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394120.